Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates macrophage-inflammatory protein-2 production, polymorphonuclear neutrophil persistence, and corneal perforation

Journal of Immunology

Volumn 164, Issue 12, 2000, Pages 6576-6582

  Rudner, Xiaowen L ^a   Kernacki, Karen A ^a   Barrett, Ronald P ^a   Hazlett, Linda D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORNEA PERFORATION; CYTOKINE PRODUCTION; EYE INFECTION; FEMALE; GRAM NEGATIVE INFECTION; INFLAMMATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RNA ANALYSIS;

EID: 0034660146     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.12.6576     Document Type: Article

References (28)

1. Laibson, P. R. 1990. Pseudomonas aeruginosa. In Current Ocular Therapy. F. T. Fraunfelder and F. H. Roy, eds. Saunders, Philadelphia, p. 35.
2. Steuhl, K.-P., G. Doring, A. Henni, H.-J. Thiel, and K. Botzenhart. 1987. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infection. Infect. Immun. 28:1559.
3. Moon, M. M., L. D. Hazlett, R. E. Hancock, R. S. Berk, and R. Barrett. 1988. Monoclonal antibodies provide protection against ocular Pseudomonas aeruginosa infection. Invest. Ophthalmol. Visual Sci. 29:1277.
4. Ohman, D. E., R. P. Burns, B. H. Iglewski. 1980. Corneal infections in mice with toxin A and elastase mutants of Pseudomonas aeruginosa. J. Infect. Dis. 142:547.
5. Hyndiuk, R. A. 1981. Experimental Pseudomonas keratitis. Trans. Am. Ophthalmol. Soc. 79:541.
6. Kernacki, K. A., J. A. Hobden, L. D. Hazlett, R. Fridman, and R. S. Berk. 1995. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection. Invest. Ophthalmol. Visual Sci. 36:1371.
7. Thiel, H.-J., K.-P. Steuhl, and G. Doring. 1987. Therapy of Pseudomonas aeruginosa eye infections. Antibiot. Chemother. 39:92.
8. Hazlett, L. D., D. D. Rosen, and R. S. Berk. 1977. Experimental Pseudomonas keratitis in immunosuppressed hybrid mice. Ophthalmic Res. 9:374.
9. Chusid, M. J., and S. D. Davis. 1979. Experimental bacterial keratitis in neutropenic guinea pigs: polymorphonuclear leukocytes in corneal host defense. Infect. Immun. 24:948.
10. Dinarello, C. A., and S. M. Wolff. 1993. The role of interleukin-1 in disease. N. Engl. J. Med. 328:106.
11. Niederkorn, J. Y., J. S. Peeler, and J. Mellon. 1989. Phagocytosis of paniculate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea. Reg. Immunol. 2:83.
12. Staats, H. F., and R. N. Lausch. 1993. Cytokine expression in vivo during murine herpetic stromal keratitis: effect of protective antibody therapy. J. Immunol. 151: 277.
13. Dinarello, C. A. 1996. Biological basis for interleukin-1 in disease. Blood 87: 2095.
14. Le, J., and J. Vilcek. 1987. Tumor necrosis factor and interleukin-1: cytokines with multiple overlapping biological activities. Lab Invest. 56:234.
15. De Vos, A. F., R. Hoekzema, and A. Kijlstra. 1992. Cytokines and uveitis, a review. Curr. Eye Res. 11:581.
16. Kernacki, K. A., D. J. Goebel, M. S. Poosch, and L. D. Hazlett. 1998. Early cytokine and chemokine gene expression during Pseudomonas aeruginosa corneal infection in mice. Infect. Immun. 66:376.
17. Hobden, J. A., S. A. Masinick, R. P. Barrett, and L. D. Hazlett. 1997. Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice. Infect. Immun. 65:2754.
18. + T cell-dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa ocular infection. J. Immunol. 159:6283.
19. Hazlett, L. D., M. M. Moon, M. Strejc, and R. S. Berk. 1985. Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea. Invest. Ophthalmol. Visual Sci. 28:1978.
20. Kernacki, K. A., R. P. Barrett, J. A. Hobden, and L. D. Hazlett. 2000. MIP-2 is a mediator of PMN influx in ocular bacterial infection. J. Immunol. 164:1037
21. Williams, R. N., C. A. Patterson, and K. E. Eakins. 1983. Quantitation of ocular inflammation: evaluation of polymorphonuclear leukocyte inflammation by measuring myeloperoxidase activity. Curr. Eye Res. 2:465.
22. Kernacki, K. A., R. Fridman, L. D. Hazlett, M. A. Lande, and R. S. Berk. 1997. In vivo characterization of host and bacterial protease expression during Pseudomonas aeruginosa corneal infections in naive and immunized mice. Curr. Eye Res. 16:289.
23. Tekamp-Olson, P., C. Gallegos, D. Bauer, J. McClain, B. Sherry, M. Fabre, S. van Deventer, and A. Cerami. 1990. Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologues. J. Exp. Med. 172:911.
24. Shams, N. B., C. V. Reddy, K. Watanabe, S. A. Elgebaly, L. A. Hanninen, and K. R. Kenyon. 1994. Increased interleukin-1 activity in the injured vitamin A-deficient cornea. Cornea 13:156.
25. Yan, X.-T., T. M. Tumpey, S. L. Kunkel, J. E. Oakes, and R. N. Lausch. 1998. Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest. Ophthalmol. Visual Sci. 39:1854.
26. Dana, M. R., J. Yamada, and J. W. Streilein. 1997. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation 63:1501.
27. Eisenberg, S. P., R. J. Evans, W. P. Arend, E. Verderber, M. T. Brewer, C. H. Hannum, and R. C. Thompson. 1990. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341.
28. Xu, W.-B., E.-B. Haddad, H. Tsukagoshi, J. Adcock, P. J. Barnes, and K. F. Chung. 1995. Induction of macrophage inflammatory protein 2 gene expression by interleukin 1β in rat lung. Thorax 50:1136.